Healthcare AI Go-to-Market

Choose the buyer who can realize the value.

I would choose the initial market by the buyer’s ability to convert a specific improvement into a funded operating result. A task can be expensive without having a budget owner willing to change it. The initial offer therefore needs three aligned parties: an executive who can fund the change, an operating leader who can redesign the work, and users whose participation determines whether the benefit appears. A commercial strategy that secures only the first party has sold a license while leaving the value proposition unresolved.

The economic mechanism determines the offer. Reducing documentation time can support clinician experience, additional appointments or lower purchased labor; each requires a different operating commitment. An authorization tool can shorten preparation while leaving the payer’s decision time unchanged. I would price and evaluate the part the product can influence, document the dependencies it cannot control, and assign implementation responsibilities before quoting a return.

The pilot should resolve the commercial uncertainty that blocks a renewable contract. That may be adoption, exception workload, integration effort or the buyer’s capacity to redeploy time. A favorable model benchmark does not settle these questions. I would define the eligible work, comparator, total delivery cost and renewal decision in advance, then test whether the same offer can serve a second account without recreating the implementation. Repeatability is the basis for expansion; a successful custom project is evidence for a services business until the delivery pattern proves otherwise.